CD274 and neoplasm: Patients with persistent tumor-associated hypoxia and high PD-L1 expression (TPS ≥1%) on tumor cells exhibited considerably inferior outcomes, while the favorable outcome of patients with early hypoxia response was independent of the tumoral PD-L1 expression.